SFI receives registration approval for both KeenMind and Nuvexa in Sri Lanka

SFI signs with new partner Ceyoka Health (Pty) Ltd to introduce new products to Sri Lanka market

SFI is pleased to announce it has received registration approval in Q2 2016 to launch both KeenMind and Nuvexa to the Sri Lankan market.

SFI will work with its new distribution partner Ceyoka Health (Pty) Ltd throughout 2016 and 2017 to introduce the two new products to pharmacies and healthcare professionals in Sri Lanka.

"While Sri Lanka is a relatively new market for us, it is a market with a deep history of natural medicine. It is fantastic opportunity to introduce KeenMind into a market in which it has historic roots. We look forward to eventually introducing a wider range of our natural products to healthcare professionals in Sri Lanka.”

SFl General Manager Asia
Robert Hendriks

Back to News